---
schema_version: "secwatch.filing_event.v1"
accession: "0000097745-25-000093"
form_type: "8-K"
ticker: "TMO"
cik: "0000097745"
company_name: "THERMO FISHER SCIENTIFIC INC."
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T04:01:03.104815+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Thermo Fisher Q2: rev +3% to $10.85B, GAAP EPS $4.28 (+6%), adj EPS $5.36

## Summary
- Q2 revenue $10.85B (+3% YoY; organic 2%); GAAP diluted EPS $4.28, up 6% from $4.04.
- Adjusted EPS $5.36 (vs $5.37); GAAP op margin 16.9% (down 40bps); adj op margin 21.9% (down 40bps).
- 2025 annual guidance to be updated during today's earnings call.
- New product launches: Orbitrap Astral Zoom MS, Krios 5 Cryo-TEM, DynaDrive bioreactor bench scale.
- Post-quarter: expanded Sanofi partnership, acquiring Ridgefield, NJ sterile fill-finish site.

## SEC filing metadata
- accession: 0000097745-25-000093
- form_type: 8-K
- ticker: TMO
- cik: 0000097745
- company_name: THERMO FISHER SCIENTIFIC INC.
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/97745/000009774525000093/0000097745-25-000093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/97745/000009774525000093/tmo-20250723.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000097745-25-000093
- JSON: https://secwatch.observer/filing/0000097745-25-000093.json
- Plain text: https://secwatch.observer/filing/0000097745-25-000093.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.